Bristol-Myers Squibb Company (BMY) Technical Analysis
Updated: 2026-06-16 09:29 UTC · Last close: 56.24 (-1.56%) · Support: 55.06 · Resistance: 57.30
Bristol-Myers Squibb Company (BMY) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
⬇️ Support
55.06
⬆️ Resistance
57.30
🚀 Bullish Trigger
a clean close above 57.30 would strengthen the upside continuation case.
🔺 Technical Setup
Pattern
Triangle Compression / SYM / UP
State
Back Inside
Trigger
56.47
Target
62.52
Risk / Invalid
53.55
Compression
63%
🎯 Decision Map
From a roadmap perspective, the setup is boxed by support near 55.07 and resistance around 57.30. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis. Pattern invalidation sits near 64.10, so a violation there would materially change the current setup narrative.
📊 Technical Summary
At a glance
Trend
Mixed
Momentum
Neutral
Range
69% of 52W range
Key Zone
55.06 / 57.30
Bristol-Myers Squibb Company (BMY) closed at 56.24 (-1.56%). Medium-term tone has softened, but price remains above MA200. Momentum: -1.33%; 52W position: 68% of range; and Volatility: ATR14 2.57%. RSI(14) stands around 47.0, which keeps the momentum picture broadly balanced. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD is positioned above the signal line, supporting a still constructive momentum backdrop. The MACD histogram remains positive, although upside momentum is not accelerating further.
🔺
Setup:
Pattern
Triangle breakout is active after price reclaimed the trigger zone.
•
Holding above 56.47 keeps the breakout structure healthier.
⚠️
Risk:
A loss of 53.55 would weaken the setup.
•
Projection target sits near 62.52.
🎯
Key levels:
Key levels
The nearest decision zone is framed by support at 55.06 and resistance at 57.30.
⚠️
Risk:
A move through resistance would improve the short-term technical tone, while a loss of support would weaken the current structure.
💼 Fundamentals Snapshot
Source: sec
💵 Revenue
11.49B
📈 Net Income
2.68B
🧮 EPS (Basic)
1.31
🏢 Company
Bristol-Myers Squibb Company
🏷 Sector
Healthcare
🧩 Industry
Pharma
Compare with related stocks
Same sector and industry ideas for deeper research
Note: This is an algorithmic technical snapshot (not financial advice).